Balaji Amines Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹468 Cr +37.2% YoYSee revenue, profit and what management said. You are viewing Q1 FY26.
BA

Balaji Amines Ltd

Q1 FY26Chemicals & Petrochemicals

Balaji Amines Q1 FY26: Revenue ₹367 Cr, PAT ₹37 Cr

Q1 FY26 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹358Cr
−7% YoY
+1.4% QoQ
Net profit
₹37Cr
−19.6% YoY
−7.5% QoQ
Margin
15%
−2 pp YoY
−2 pp QoQ

Based on Balaji Amines Ltd's Q1 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹2,226
Market cap₹7.0K Cr
P/E34.5

The short version

Q1FY26 consolidated revenue from operations: ₹367 crore, up 2% quarter-on-quarter from ₹361 crore in Q4FY25, but down 7% year-on-year from ₹393 crore in Q1FY25 (Page 6, 5). Q1FY26 EBITDA: ₹64 crore, down from ₹74 crore in Q1FY25 (−14% YoY) - Q1FY26 EBITDA Margin: 17%, decreased from 19% in Q1FY25 - Q1FY26 Profit After Tax (PAT): ₹37 crore, down from ₹46 crore in Q1FY25 (−20% YoY) - Q1FY26 PAT Margin: 10%, down from 12% in Q1FY25

From Balaji Amines Ltd's Q1 FY26 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Q1FY26 consolidated revenue from operations: ₹367 crore, up 2% quarter-on-quarter from ₹361 crore in Q4FY25, but down 7% year-on-year from ₹393 crore in Q1FY25 (Page 6, 5).
  • Total volumes for Q1FY26: 27,570 MT, up from 25,871 MT in Q4FY25;
  • Segment volumes Q1FY26: Amines - 7,573 MT; Amines Derivatives - 8,108 MT; Specialty Chemicals - 11,889 MT (Page 6).

2 more points from Balaji Amines Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Balaji Amines Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Unit 4 Phase 2 & 3 Greenfield Capex at Subsidiary Plant to complete by FY26, including products like HCN, NaCN (30% solution, 100% solid), EDTA, Benzyl Cyanide, Phenylacetic Acid, TEOF/TMOF (Page 33, 25).
  • Methylamines Plant expansion from 48,000 TPA to 88,000 TPA, commissioned Nov 10, 2024 (Page 9).
  • Dimethyl Ether (DME) plant (1,00,000 TPA), under erection, to be commissioned FY25-26 (Page 9).
  • N-Methyl Morpholine (NMM) facility (15 MT/day), under development, majority equipment procured, commissioning in FY25-26 (Page 9).
  • Iso Propyl Amine plant (20-21 MT/day), modifications underway, commissioning post MPCB approval (Page 9).
  • ACN plant technology upgrade and capacity increase, commissioning in FY26-27 (Page 9).

2 more points from Balaji Amines Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Balaji Amines Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Balaji Amines Ltd said on order book & pipeline — free account, 30 seconds.

Balaji Amines Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Balaji Amines Ltd Q1 FY26 results — key figures

Balaji Amines Ltd Q1 FY26 reported results vs Q1 FY25, ₹ crore
₹ CrQ1 FY26Q1 FY25YoYQ4 FY25QoQ
Revenue358385-7%353+1.4%
Operating profit (EBITDA)5566-16.7%60-8.3%
Operating margin15%17%-2 pp17%-2 pp
Profit before tax4962-21%54-9.3%
Net profit (PAT)3746-19.6%40-7.5%
EPS (₹)11.7313.36-12.2%12.36-5.1%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹468 Cr, net profit ₹67 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Linde India (Q1 FY26)

    Net Revenue for FY ended Mar’25 was INR 24,854 million, down 10.2% (–2,833 million) YoY from INR 27,687 million. Key concall takeaways from Linde India Ltd's…

  • Vidhi Specialty (Q1 FY26)

    87.9 Crores . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

  • Chemcon Speciality Chemicals (Q1 FY26)

    Q1 FY26 revenue from operations: ₹53.5 Cr, up 18% YoY from ₹45.5 Cr in Q1 FY25 (Page 7 & 6). Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q1…

  • Valiant Organics (Q1 FY26)

    FY22: INR 1,153 Cr . Key concall takeaways from Valiant Organics Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Balaji Amines Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Balaji Amines Ltd Q1 FY26 results?

Q1FY26 consolidated revenue from operations: ₹367 crore, up 2% quarter-on-quarter from ₹361 crore in Q4FY25, but down 7% year-on-year from ₹393 crore in Q1FY25 (Page 6, 5). Q1FY26 EBITDA: ₹64 crore, down from ₹74 crore in Q1FY25 (−14% YoY) - Q1FY26 EBITDA Margin: 17%, decreased from 19% in Q1FY25 - Q1FY26 Profit After Tax (PAT): ₹37 crore, down from ₹46 crore in Q1FY25 (−20% YoY) - Q1FY26 PAT Margin: 10%, down from 12% in Q1FY25

What is Balaji Amines Ltd share price analysis?

Balaji Amines Ltd currently shows a neutral. The stock trades at a P/E of 34.5 with a market cap of ₹7,036 Cr. Investors should review the full earnings analysis for detailed insights.

Is Balaji Amines Ltd planning capital expenditure?

Unit 4 Phase 2 & 3 Greenfield Capex at Subsidiary Plant to complete by FY26, including products like HCN, NaCN (30% solution, 100% solid), EDTA, Benzyl Cyanide, Phenylacetic Acid, TEOF/TMOF (Page 33, 25).

Keep Balaji Amines Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.